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http://www.biomedcentral.com/1471-2296/15/72RESEARCH ARTICLE Open AccessAwareness, agreement, adoption and adherence
to type 2 diabetes mellitus guidelines: a survey of
Indonesian primary care physicians
Indah S Widyahening1,2*, Yolanda van der Graaf2, Pradana Soewondo3, Paul Glasziou4 and
Geert JMG van der Heijden5Abstract
Background: To assess the degree of awareness, agreement, adoption and adherence of physicians in Indonesia
to type 2 diabetes mellitus guidelines, and their association with characteristics of the responders.
Methods: Questionnaire survey among General Practitioners (GPs) attending the Indonesian Association of Family
Practitioners annual conference in November 2012. The proportion of GPs who were aware of, agreed with,
adopted and adhered to the seven recommendations in the guidelines (screening for diabetes, diagnosis, lifestyle
modification, use of sulfonylurea, target blood glucose, target blood pressure and use of statin) were calculated in
the total number of responders.
Results: Of the 399 GPs participating, 383 (89%) were aware of the existence of Indonesian type 2 diabetes
guidelines. Awareness for each recommendation varied from 66 to 91%. The recommendation to use a random
blood glucose test for diagnosing patients with classic diabetes symptoms had the least awareness (265/399, 66%)
and least agreement (163/399, 41%). The recommendation on statin use was the least adopted (192/399, 48%),
while the least adherence (7/399, 2%) was found for the recommendation on screening for diabetes for patients
with risk factors. Years of practice experience and proportion of diabetes patients seen in their practice were
independently related with adherence to statin prescription.
Conclusions: High awareness of the Indonesian type 2 diabetes guideline does not necessary lead to adoption or
adherence to recommendations important for outcomes and quality of care. The awareness-to-adherence model
helps in identifying barriers for the use of guidelines.
Keywords: Awareness, Adoption, Adherence, Diabetes, Guidelines, General practitionersBackground
A study by the World Health Organization (WHO) esti-
mated that the total number of people with diabetes will
increase from 171 million in 2000 to 366 million in 2030;
mostly in developing countries [1]. This is due to popula-
tion growth, aging, urbanization, and increasing preva-
lence of obesity and physical inactivity. The Basic Health
Research Survey conducted by the Indonesian Ministry of
Health in 2007 involved 24,417 participants living in* Correspondence: indah_widyahening@ui.ac.id
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article, unless otherwise stated.urban area from all over Indonesia found that the preva-
lence of diabetes in Indonesia was about 6%, and about
two thirds of that percentage are unaware that they have
diabetes [2]. Therefore, Indonesia became the seventh
largest country with diabetes people in the world [3].
Diabetes mellitus is a complex chronic disease that re-
quires lifelong self-management and continuous medical
care to prevent its acute complications and reduce its as-
sociated chronic health risks [4]. Type 2 diabetes, which is
resulted from a progressive insulin secretory defect on the
background of insulin resistance has been recognized as
an emerging health problem in Asia Pacific, including
Indonesia. On the other hand type 1 diabetes, which is re-
sulted from β-cell destruction is less common in theentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Table 1 Recommendations of the Indonesian type 2
Diabetes Mellitus guideline assessed in the questionnaire
Statements in the guideline
Recommendation 1 Screening for type 2 diabetes should
be performed in all patients with any
of the risk factor listed in the guidelines.
Recommendation 2 In patients with classic DM symptoms,
one random blood (plasma) glucose test
with result >200 mg/dL is enough to
confirm the diagnosis.
Recommendation 3 For newly diagnosed patients,
management should be started with
meal planning and exercise for
2–4 weeks.
Recommendation 4 Sulfonylurea is the drug of choice for
normal and underweight patients.
Recommendation 5 Most patients should achieve Fasting
Blood Glucose (FBG) of <100 mg/dL
and 2-hour post-prandial Blood Glucose
(2-h pp BG) of <140 mg/dL.
Recommendation 6 Blood pressure should be reduced to
below 130/80 mmHg.
Recommendation 7 Statin should be prescribed to people
with type 2 diabetes who are over
40 years old or have CVD risk.
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Indonesian guidelines on diabetes management seems in-
sufficient to achieve the targets in diabetes control. Cur-
rently, about 68% of type 2 diabetes patients being cared in
secondary and tertiary hospitals in Indonesia have poor
blood glucose control (HbA1c > 7% or >53 mmol/mol) [6].
Guidelines may assist patients and health professionals
in achieving optimal management of diabetes. The
Indonesian Society of Endocrinology (Perkeni) intro-
duced a guideline on the management and prevention of
type 2 diabetes mellitus in 1993, and revised it on regular
basis since then [7]. This guideline provides selected re-
commendations that have been derived from a selection
of internationally established guidelines [4,8-10] and
consensus of Indonesian experts in endocrinology.
Several surveys have shown that the adherence varies
per guideline recommendation [11-15]. Barriers to guide-
line adherence have been identified, including the inability
to access guidelines and physicians’ attitude and belief to-
ward the guidelines [16]. Pathman et al. reported that for
the consistency between patient care and guidelines re-
commendations, physicians must be aware of, agree with,
decide to adopt (i.e. decide it is appropriate and feasible to
use in their own practice), and adhere to the recommen-
dations (i.e. actually follow them for appropriate patients
at the appropriate time) [17,18]. Several studies have been
conducted based on this ‘awareness to adherence’ model,
yet only one came from developing countries [17].
We would like to know whether this model applies also
for a developing country like Indonesia. In this study we
explore the degree of general practitioners’ awareness of
agreement with, adoption of and adherence to the type 2
diabetes mellitus guidelines in Indonesia, and identify
associated physicians’ characteristics.
Methods
Questionnaire design and data collection
Based on the evaluation of hypertension guidelines ques-
tionnaire by Heneghan et al. [19], we developed a similar
questionnaire centered on items in the Consensus on the
Management of Type 2 Diabetes Mellitus 2011 of the
Indonesian Society of Endocrinology [7]. We included
questions on the respondent characteristics: gender, age,
specialization, practice duration, type of practice, location
of practice, previous participation on type 2 diabetes man-
agement training and number and proportion of diabetes
patients seen in their practice. According to the guideline
recommendations we grouped the questionnaire content
into screening, diagnosis, treatment, life-style modification,
management of co-morbidities and diabetes complications
(Table 1). For the nominal and ordinal response options
we followed the Pathman ‘awareness-to-adherence’ model,
notably awareness (Yes/no), agreement (Yes/Unsure/No),
and adoption (i.e. the recommendation is being followed ingeneral in the appropriate patients; always/more than half/
less than half/never). Adherence was assessed with an open
ended question about the system responders had in place
to promote or monitor the guideline application.
The questionnaire was pilot tested to five GPs from
the Community Medicine Department of the Faculty of
Medicine Universitas Indonesia to determine whether the
questions were clear, understandable, and in a logical
order (face validity). Moreover the same GPs and three
endocrinologists who are familiar with the diabetes guide-
line were asked to criticize the content of the question-
naire (content validity). Based on the results of this pilot,
minor changes were made. Further psychometric evalu-
ation of the reliability was not performed.
The final questionnaire was distributed to all physi-
cians attending the Indonesian Association of Family
Practitioners annual conference on November 2012 in
Jakarta, Indonesia. The questionnaire was put in the
delegates pack together with an information leaflet on
consent for survey participation. Returning of the self-
completed questionnaire by responders was seen as their
token of consent. Before handing out their certificate of
attendance conference participants were informed about
the possibility of participation. The Health Research
Ethics Committee of the Faculty of Medicine Universitas
Indonesia reviewed and approved the study.
Analyses and coding of data
We explored the association between respondent cha-
racteristics and adherence to each of the seven guideline
Table 2 Characteristics of the GP responders
Characteristics n (%) Mean (SD) Min-max
Years of practicea 15.7 (8.8) 0-45 years
Gendera
Male 126 (32)
Female 273 (68)
Practice typea
Solo practice 215 (54)
Private clinic 64 (16)
Public health center 86 (22)
Private hospital 20 (5)
Public hospital (non academic) 8 (2)
Academic hospital 6 (1)
Practice locationc
Jakarta 119 (30)
Outside Jakarta but within
Java island
167 (42)
Outside java 113 (28)
Participation in DM trainingb
Yes 234 (64)
No 165 (36)
Number of DM patients seen
in a weekc
13.0 (15.9) 1-120
Proportion of DM patients
among all patients seena
<10% 261 (66)
10-30% 117 (29)
>30% 21 (5)
Awareness to DM consensusa
Never knew 43 (11)
Heard but never had a copy 138 (36)
Had but never read the consensus 78 (20)
Has read and implemented it 124 (33)
Missing data: a:<5%; b:5-10%; c:>10-15%.
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regression analysis. To prevent for a type 2 error, only GP
characteristics with a univariate p-value of 0.20 or less
were selected for such multivariate analyses. The outcome
for these data analyses was the number of responders’ ad-
herent to a recommendation. To prevent for spurious
findings at least 10 participants adherent to the recom-
mendation were needed for each respondent characteristic
included in the multivariable analysis [20]. We used SPSS,
version 20.0 for Windows (SPSS Inc., Chicago, IL, USA)
for all data analysis.
Responders were classified as ‘unaware of a recommen-
dation’ if they answered “no” on the question on familia-
rity with that recommendation. Agreement was classified
according to whether they agreed or not with the guide-
line. They were considered to have adopted a guideline
when they reported implementing it ‘more than half of
the time’. They were considered to adhere to the recom-
mendation when they ‘always’ or ‘more than half of the
time’ applied it in clinical practice and specified the system
they used to promote or monitor application. The propor-
tions of doctors who were aware of, agreed with, adopted
and adhered to each recommendation were calculated
over the total number of responders.
Years of practice experience was grouped in 15 years
or less and more than 15 years. The Perkeni guideline
was firstly introduced in 1993. Therefore we assume that
GPs who practiced less than 15 years should be aware of
the guideline during their medical training.
We assumed the missing outcome data to represent
no awareness, no agreement, no adoption and no ad-
herence. For respondent characteristics with up to 15%
missing data, we used conditional imputation, imput-
ing the mean or median. We used mean and median
values for imputation since we thought we had not the
proper participant characteristic’s to do regression ana-
lyses for imputation.
Results
From the 662 conference participants, 414 questionnaires
(63%) were collected. We included 399 (96%) question-
naires from GPs and excluded 3 questionnaires from spe-
cialists and 12 from other health care professionals (e.g.
nurses and dietician/nutritionists). The missing data for
awareness, agreement, adoption and adherence ranged
from none to 10%. Adherence to screening had no missing
data, while the proportion of missing data for adherence
to statin was highest (10%). Three participant characteris-
tics had 5% or more missing data, with a maximum of
15% for number of diabetes patients seen in a week.
Characteristics of the GP responders are presented in
Table 2. The higher proportion of them were female
(68%), doing a solo (individual) practice (54%), practiced
in Java-the most populated island in Indonesia (72%) andhad participated in diabetes management training (64%).
Three-hundred forty of 383 GPs (89%) were aware of the
consensus on the management of type 2 diabetes by the
Indonesian Society of Endocrinology.
Figure 1 shows the proportions of the responders who
were aware of, agreed with, adopted and adhered to the
recommendations of the Indonesian type 2 diabetes mel-
litus guidelines. Awareness of each recommendation va-
ried between 66 to 91% while agreement with varied
between 41 to 87%. The least aware (265/399, 66%) and
least agreed (163/399, 41%) recommendation was on the
use of random blood (plasma) glucose test to diagnose
patients with classic diabetes symptoms.
Adoption varied between 48 to 68%. The least adopted
was statin use in type 2 diabetes who are over 40 years
Figure 1 Proportions of awareness, agreement, adoption, and adherence of GPs (n = 399) to selected recommendations from the
Indonesian type 2 Diabetes Mellitus (T2DM) guidelines. Proportions (%) were computed based on the total GPs responders. Missing data
was: <5% for screening (all), diagnosis (all), lifestyle modifications (awareness, agreement and adoption), and adherence on sulfonylurea. 5-10% for
adherence on lifestyle modification, sulfonylurea (awareness, agreement and adoption), blood glucose target (all), blood pressure target (all) and
statin prescription (all).
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between 2 to 45%, while the least adherence was on the
recommendation to perform type 2 diabetes screening
in patients with any risk factor listed in the guideline
(7/399, 2%).
The summary of the univariate associations (p ≤ 0.2)
for six participant characteristics on adherence to the
six recommendations can be found in Table 3 and the
multivariate associations in Table 4. We were not able to
investigate the presence of participant characteristics on
the adherence to screening as the number of events was
too small (7 events).
None of the participant characteristics were neither
univariately nor multivariately associated with the re-
commendation on the diagnosis of diabetes (#2), Sulfo-
nylurea for treatment (#4) and using blood pressure as
treatment target (#6). During univariate regression ana-
lysis, years of practice, practice type and practice location,
were associated with the recommendation on lifestyle
modification (#3). However, none of these were retained
during subsequent multivariate analysis. Only the pro-
portion of diabetes patients was univariately associated
with the recommendation on blood glucose as treat-
ment target (#5).
During both univariate and subsequent multivariate
analysis, adherence to the recommendation on statin
prescription (#7) was found poor for responders with a
practice prevalence of less than 10% diabetes patients(OR = 0.7, 95% CI 0.4;1.0, p = 0.08) and those practicing
15 years or less (OR =0.7, 95% CI: 0.4;1.0, p = 0.07).
Discussion
This study shows that awareness and agreement of the
GPs of the seven recommendations of the Indonesian type
2 diabetes mellitus guideline was quite high (66 to 91%).
The high awareness of GPs and their familiarity with the
guideline is most likely due to the extensive promotion
and marketing efforts on the introduction of the Indones-
ian Society of Endocrinology guidelines. Despite this high
awareness, a large number of GPs neither adopted nor
adhered to the guideline recommendations. A practice
prevalence of less than 10% diabetes patients and prac-
ticing 15 years or less were independently related with
poor adherence to statin prescription.
Awareness – agreement – adoption and adherence to the
recommendations
There was high awareness among responders on the need
for screening for type 2 diabetes risk factors among those
without diabetes symptoms. Still, most of our responders
waited until several cardiovascular risk factors emerged
in the patient before they advised a screening test to
the patient or they did not have a system to identify pa-
tients with risk factors. This was indicated by an extremely
low (2%) adherence to the screening recommendation for
identification of type 2 diabetes. This result is in contrast
Table 3 Univariate associations (odds ratio and their 95% CI) between GPs (n = 399) characteristics and adherence to
Indonesian type 2 Diabetes Mellitus (T2DM) guideline recommendations
Diagnosis Lifestyle
modification
Sulfonylurea for
treatment
Blood glucose
target
Blood pressure
target
Statin
prescription
Adherent participants: n (%) 67 (45) 145 (36) 111 (37) 61 (21) 113 (28) 118 (34)
Characteristics
Years of practice
16 – 45*
0 – 15 1.2 (0.8-1.7)b 1.4 (0.9-2.2)c 0.8 (0.6-1.3)b 0.8 (0.5-1.3)c 1.0 (0.7-1.6)c 0.7 (0.5-1.1)c
Gender
Female*
Male 1.1 (0.7-1.7)a 0.7 (0.5-1.2)b 1.3 (0.8-2.0)a 0.8 (0.5-1.4)b 0.8 (0.5-1.3)b 1.0 (0.6-1.6)b
Practice type
Non solo practice*
Solo practice 0.8 (0.6-1.2)a 0.7 (0.5-1.1)c 0.9 (0.6-1.3)b 1.0 (0.6-1.7)c 1.2 (0.8-1.9)c 1.0 (0.6-1.4)b
Practice location
Outside Jakarta*
Jakarta 0.9 (0.6-1.4)c 1.5 (1.0-2.3)d 1.0 (0.6-1.6)c 0.8 (0.5-1.4)d 1.1 (0.7-1.7)d 1.1 (0.7-1.7)d
DM training
No*
Yes 1.1 (0.7-1.7)b 1.3 (0.8-2.0)d 1.2 (0.8-1.9)c 1.0 (0.6-1.7)d 1.0 (0.6-1.6)d 1.1 (0.7-1.7)d
Proportion DM patients
10% and above*
<10% 1.0 (0.7-1.5)b 0.8 (0.5-1.2)c 0.9 (0.6-1.4)b 1.5 (0.9-2.5)c 1.1 (0.7-1.8)c 0.7 (0.5-1.1)c
Missing data: a:0- < 5%, b:5-10%, c:>10-15%, d:>15-19%.
*reference.
Adherence to screening was not included in the univariate analysis since the number of events were too small (seven events).
Associations which have p value <0.2,
• Life-style modification: years of practice, practice type, practice location.
• Blood glucose target: proportion of diabetes patients.
• Statin: years of practice, proportion of diabetes patients.
• Diagnosis, sulfonylurea for treatment and blood pressure target: none.
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adherence to the screening of diabetes which reach
83% [21].
We found the least agreement (41%) with the recom-
mendation to use random blood (plasma) glucose in the
diagnosis of diabetes in patients with classic diabetes
symptoms. The majority of our responders believed it is
more appropriate to examine patients with classic dia-
betes symptoms with a fasting plasma glucose test and
2-hour post-prandial plasma glucose test. Due to the
fasting needed for these blood sugar tests, patients may
delay or avoid the examination.
On statin prescription, we found that the level of
awareness and adoption were the lowest (72% and 52%).
With 32% adherence among our responders to the re-
commendation to prescribe statins, it is slightly higher
than in a Seoul tertiary hospital (29%) [14] but much
lower than the 68% adherence among Australian GPs
[11]. Factors related to the adherence to the recommen-
dation to prescribe statins in our study were more yearsof practice experience and larger proportion of diabetes
patients the practice.
Adoption to guideline recommendations has been shown
to be facilitated by the acquisition of the necessary know-
ledge and skills. High health costs for patients and practice,
patient’s knowledge, expectations, compliance, moti-
vation and support for recommendation, lack of materials,
logistic support and time of health professionals, and
high proportions of patients without insurance have
been reported as barriers to guidelines adherence [16,17].
Adherence to actions recommended in guidelines may
require practice organization. Besides, adherence is fa-
cilitated when tools are in place to put the recommenda-
tions into practice [22]. A systematic review [17] reported
a median adherence of 36% (Inter Quartile Range 30 to
56%) to recommendations from various guidelines. Our
data reveal that adherence to all the recommendations
was quite low since less than 50% responders did not
implement a system to promote and monitor recom-
mendations in their practice.
Table 4 Independent associations (multivariate odds ratio and their 95% CI) between GPs (n = 399) characteristics and
adherence to Indonesian type 2 Diabetes Guidelines recommendations
Lifestyle modification Blood glucose target Statin prescription
Characteristics OR (95% CI) p OR (95% CI) p OR (95% CI) p
Years of practice
16 – 45*
0 – 15 1.2 (0.7-2.2)c 0.50 - 0.7 (0.4-1.1)c 0.07
Gender
Female*
Male 0.9 (0.5-1.4)b 0.51 - -
Practice type
Non solo practice*
Solo practice 0.9 (0.5-1.3)c 0.51 - -
Practice location
Outside Jakarta*
Jakarta 1.3 (0.8-2.1)d 0.29 - -
DM training
No*
Yes - - -
Proportion DM patients
10% and above*
<10% 0.8 (0.5-1.3)c 0.37 1.5 (0.9-2.5)c 0.16 0.7 (0.4-1.1)c 0.08
Missing data: a:0- < 5%, b:5-10%, c:>10-15%, d:>15-19%.
*reference.
Adherence to screening was not included in the multivariate analysis as the number of events were too small.
Adherence to recommendations on diagnosis, treatment and blood pressure target have no characteristic factors univariately associated (p-value ≤ 0.20) with
them (see Table 3).
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dation on screening and diagnosis may explain why two
thirds of the diabetes population in Indonesian remain
un-diagnosed [2]. The generally low adherence to the
recommendations of the Indonesian guideline may
partly explain the finding by Soewondo et al. that 68% of
patients in Indonesia diagnosed with diabetes were in
poor glycemic control [6].
Pattern of leakage
Based on a systematic review on the utilization of clinical
guidelines [17] we expected to find a consistent pattern of
‘leakage’, i.e. lower number of positive responders, over
the four subsequent steps of the Pathman’s awareness-to-
adherence model. In our study, adoption and adherence
rates are generally progressively lower, except for the re-
commendations on diagnosis of diabetes and sulfonylurea
treatment.
Our findings on the non-progressiveness of the recom-
mendation on diagnosis of diabetes and sulfonylurea
treatment deserve further consideration. As was stated
previously, a majority of our responders believed that
fasting and 2-hour post-prandial blood (plasma) glucose
test are more appropriate than random blood (plasma)glucose in the diagnosis of diabetes in patients with clas-
sic diabetes symptoms. However, random blood glucose
is more practical to be implemented in the practice so it
is more adopted.
The Indonesian guideline recommends sulfonylurea as
the drug of choice to manage hyperglycemia in normal
and underweight type 2 diabetes patients. In all, 58% of
our responders agree with this recommendation. In con-
trast to the Indonesian guidelines, the consensus statement
of the American Diabetes Association and the European
Association for the Study of Diabetes recommends simul-
taneous initiation of metformin and lifestyle intervention
at diagnosis [10]. Familiarity with this ADA/EASD recom-
mendation may cause some uncertainty, but metformin
and other classes of blood glucose–lowering medications
are not generally available in primary health centers [23].
This may explain why agreement with sulfonylurea as
recommended treatment is lower than its adoption.
Strengths and limitations of the study
Our study supports the usefulness of the awareness-to-
adherence model and provides valuable information on
the utilization of an important guideline in Indonesia. Still,
some aspects of our study, notably the sampling method,
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self-reporting questionnaire, need further consideration.
Obtaining representative samples from the large num-
ber of Indonesian GPs, exceeding 70,000, who are dis-
tributed over the archipelago possess challenges for our
type of research.
Recruitment of responders among those attending a
conference in Jakarta (capital city of Indonesia) was seen
as more practical although it might not represent phy-
sicians who do not have opportunity to attend such
meeting. However, our responders represent GPs from
all parts of Indonesia. Our response rate is within the
range of that of similar studies as reported by the
systematic review of Mickan et al. [17].
Self-reporting is the most simple and inexpensive
method of measuring adherence. However, it has several
limitations including over-estimation due to recall bias
and social desirability bias [24]. These drawbacks have
been addressed through determination of specific time
period in the questionnaire, assessment of specific be-
havior related to the recommendations, non-judgmental
statements and confidentiality.
The awareness-to adherence model may help to iden-
tify GPs’ specific concerns with recommended practice
changes. If uptake of a specific recommendation is low,
qualitative approach to the concerns and barriers might
be useful. Implementation of a quality assurance system
which could further illustrate the care being received by
diabetes patients in relation to the clinical outcomes is
believed to be beneficial to promote adherence to guide-
line recommendations and increase the quality of diabetes
care [25].
Conclusions
Our study shows that high awareness of the guideline
does not always lead to adoption nor adherence to its
recommendations. The production and dissemination of
guidelines alone is not sufficient to ensure that research
evidence gets into practice. Improvement of clinicians’
awareness of, agreement with, and adoption to guide-
lines need to be incorporated in to strategies to improve
guideline adherence.
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